Herombopag for Chemotherapy-induced Thrombocytopenia
Clinical trial NCT05236582 · RECRUITING
Trial details
- NCT number
- NCT05236582
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-14
- Primary completion
- 2024-12-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.